Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Myomo, Inc. develops wearable robotic devices, primarily the MyoPro upper limb orthosis, to assist individuals with neuromuscular disorders and paralysis. The company’s products leverage patented EMG control technology to enable users to regain arm and hand function. Serving healthcare providers, insurance payers, and international markets, Myomo focuses on innovative, custom-fabricated solutions that improve independence and quality of life for patients with neurological impairments.
This description was generated via AI from an annual report. Updated about 1 year ago.